Candidiasis in the transplant patient.

The widely accepted practice of empirically administering amphotericin B to immunocompromised patients with fever unresponsive to antibiotics poses a hazard to transplant recipients receiving immunosuppression with cyclosporine. Improved methods of Candida detection and less toxic antifungals are urgently needed, but in the interim, treatment regimens should require a greater index of suspicion before initiating amphotericin therapy in patients receiving cyclosporine.